LianBio Debt Securities, Available-for-sale, Unrealized Loss Position
LianBio (LIANY) had Debt Securities, Available-for-sale, Unrealized Loss Position of $148.76 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2023-11-13
- 2023-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $148.76M.
- 2023-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $149.27M.
- 2023-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $139.51M.
- 2022-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $210.17M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2023-09-30 | $148.76M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $149.27M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $139.51M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $210.17M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $223.39M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $194.97M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $229.28M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $4.98M 10-K · filed 2023-03-28 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 |